Area of research
Immunology · Biotechnology
Research interest
Research focused on RHOA and Pembrolizumab, with related work in Cell polarity, Cell biology, Sting. Notable publications include 'Confinement hinders motility by inducing RhoA-mediated nuclear influx, volume expansion, and blebbing', 'Polarized NHE1 and SWELL1 regulate migration direction, efficiency and metastasis', and 'Dorsoventral polarity directs cell responses to migration track geometries'.
Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
Cytokinesis machinery promotes cell dissociation from collectively migrating strands in confinement
Polarized NHE1 and SWELL1 regulate migration direction, efficiency and metastasis
Dorsoventral polarity directs cell responses to migration track geometries
Confinement hinders motility by inducing RhoA-mediated nuclear influx, volume expansion, and blebbing